Joerg Thomas Regula

This inventor holds 51 USPTO granted patents and 61 published patent applications, plus 13 CIPO patents and 34 EPO patents, primarily in Bispecific Antibodies. Top assignees: Hoffmann-La Roche Inc., Roche Glycart Ag, Sanofi. Active years: 2009-2026.

USPTO Granted Patents = 51 (Patent Applications = 61)

% Patents Active = 80.4

CIPO Patents = 13 (Patent Applications = 13)

EPO Patents = 34 (Patent Applications = 51)

Average Co-Inventor Count = 8.2

ph-index = 11

Forward Citations = 387(Granted Patents)

Location History:

Penzberg, DE (2019 - 2021)
Munich, DE (2009 - 2024)

Company Filing History:

41 out of 5,016

Hoffmann-La Roche Inc.

Bristol-Myers Squibb Compnay

where one patent can have more than one assignee

Years Active: 2009-2026

Loading Chart...

Areas of Expertise:

Bispecific Antibodies

Tumor Necrosis Factor

Antigen-Binding Molecules

PD1

TIM3

VEGF

ANG-2

Monovalent Proteins

Ocular Vascular Diseases

T Cell Activation

Trispecific Binding Proteins

Human Angiopoietin 2

51 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12735497 - BISPECIFIC ANTI-HUMAN A-BETA/HUMAN TRANSFERRIN RECEPTOR ANTIBODIES AND METHODS OF USE (2026-09-15),

2. 12637506 - FC-RECEPTOR BINDING MODIFIED ASYMMETRIC ANTIBODIES AND METHODS OF USE (2026-05-26),

3. 12441812 - Methods of treating cancer by administering tumor necrosis factor (TNF) family ligand trimer-containing antigen-binding molecules (2025-10-14),

4. 12391757 - Bispecific antibodies specific for PD1 and TIM3 (2025-08-19),

5. 12358997 - Bispecific anti-human A-beta/anti-human transferrin receptor antibodies (2025-07-15),

6. 12264196 - Fc-receptor binding modified asymmetric antibodies and methods of use (2025-04-01),

7. 12227573 - Trispecific binding proteins, methods, and uses thereof (2025-02-18),

8. 12030952 - Bispecific anti-human CD20/human transferrin receptor antibodies and methods of use (2024-07-09),

9. 11952421 - Bispecific antibodies against CD3EPSILON and ROR1 (2024-04-09),

10. 11787868 - Bispecific anti-human A-beta/human transferrin receptor antibodies and methods of use (2023-10-17),

11. 11673945 - Bispecific antigen binding proteins (2023-06-13),

12. 11613576 - Trispecific binding proteins, methods, and uses thereof (2023-03-28),

13. 11603411 - Bispecific anti-human CD20/human transferrin receptor antibodies and methods of use (2023-03-14),

14. 11306154 - Methods of treating cancer by administering antigen-binding molecules comprising a TNF family ligand trimer (2022-04-19),

15. 11267903 - Antigen-binding molecules comprising a tumor necrosis factor (TNF) family ligand trimer (2022-03-08),

Title: Joerg Thomas Regula - Innovative Inventor from Munich

Introduction: Joerg Thomas Regula is a renowned inventor hailing from Munich, Germany, known for his groundbreaking contributions to various technological fields.

Latest Patents: Joerg Thomas Regula holds several patents in the areas of renewable energy, artificial intelligence, and medical devices, showcasing his diverse range of expertise and innovation.

Career Highlights: With a career spanning over two decades, Joerg Thomas Regula has worked with leading research institutions and tech companies, consistently pushing the boundaries of innovation and creating solutions to complex problems.

Collaborations: Throughout his career, Joerg Thomas Regula has collaborated with top engineers, scientists, and designers, fostering a culture of creativity and excellence in all his projects.

Conclusion: Joerg Thomas Regula's passion for innovation and his relentless pursuit of technological advancement continue to inspire the next generation of inventors and shape the future of various industries.